Influence of Low-Density Lipoprotein Cholesterol Levels on NSAID-Associated Cardiovascular Risks After Myocardial Infarction: A Population-Based Cohort Study

References

• McGettigan P, Henry D. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries. PLoS Med. 2013;10(2):e1001388. doi:10.1371/journal.pmed.1001388
   PubMed Web of Science ®Google Scholar
• Schmidt M, Hallas J, Friis S. Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999–2012. Clinical Epidemiology. 2014;6:155. doi:10.2147/CLEP.S59156
   PubMed Web of Science ®Google Scholar
• Boulakh L, Gislason GH. Treatment with non-steroidal anti-inflammatory drugs in patients after myocardial infarction - A systematic review. Expert Opin Pharmacother. 2016;17(10):1387–1394. doi:10.1080/14656566.2016.1186648
   PubMed Web of Science ®Google Scholar
• Gislason GH, Jacobsen S, Rasmussen JN, et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation. 2006;113(25):2906–2913. doi:10.1161/CIRCULATIONAHA.106.616219
   PubMed Web of Science ®Google Scholar
• Kang DO, An H, Park GU, et al. Cardiovascular and bleeding risks associated with nonsteroidal anti-inflammatory drugs after myocardial infarction. J Am Coll Cardiol. 2020;76(5):518–529. doi:10.1016/j.jacc.2020.06.017
   PubMed Web of Science ®Google Scholar
• Sørensen R, Abildstrom SZ, Torp-Pedersen C, et al. Use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs in high doses increases mortality and risk of reinfarction in patients with prior myocardial infarction. J Cardiovasc Nurs. 2008;23(1):14–19. doi:10.1097/01.JCN.0000305054.50506.59
   PubMed Web of Science ®Google Scholar
• Kohli P, Steg PG, Cannon CP, et al. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease. Am J Med. 2014;127(1):53–60.e1. doi:10.1016/j.amjmed.2013.08.017
   PubMed Web of Science ®Google Scholar
• Schjerning Olsen AM, Fosbøl EL, Pallisgaard J, et al. NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study. Eur Heart J Cardiovasc Pharmacother. 2015;1(2):107–114. doi:10.1093/ehjcvp/pvv004
   PubMedGoogle Scholar
• Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. new perspectives based on the Framingham study. Ann Intern Med. 1979;90(1):85–91. doi:10.7326/0003-4819-90-1-85
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pottegård A. Prescriber responsibility, predictors for initiation, and 20-year trends in use of non-aspirin non-steroidal anti-inflammatory drugs in patients with cardiovascular contraindications: a nationwide cohort study. Eur Heart J Cardiovasc Pharmacother. 2020;7:496–506
   Web of Science ®Google Scholar
• Danelich IM, Wright SS, Lose JM, et al. Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease. Pharmacotherapy. 2015;35(5):520–535. doi:10.1002/phar.1584
   PubMed Web of Science ®Google Scholar
• Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–584. doi:10.1038/s41569-020-0366-z
   PubMed Web of Science ®Google Scholar
• Schmidt M, Jacobsen JB, Lash TL, et al. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ. 2012;344:e356. doi:10.1136/bmj.e356
   PubMed Web of Science ®Google Scholar
• Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370(9602):1829–1839.
   PubMed Web of Science ®Google Scholar
• Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644–1652. doi:10.1016/S0140-6736(20)32233-9
   PubMed Web of Science ®Google Scholar
• Schmidt M, Lamberts M, Olsen A-MS, et al. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for cardiovascular pharmacotherapy of the European society of cardiology. Eur Heart J. 2016;37(13):1015–1023. doi:10.1093/eurheartj/ehv505
   PubMed Web of Science ®Google Scholar
• Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, et al. Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46(3):798. doi:10.1093/ije/dyw213
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sørensen HT. The Danish Civil registration system as a tool in epidemiology. Eur j epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish national patient registry: A review of content, data quality, and research potential. Clinical Epidemiology. 2015;7:449. doi:10.2147/CLEP.S91125
   PubMed Web of Science ®Google Scholar
• Arendt JFH, Hansen AT, Ladefoged SA, et al. Existing data sources in clinical epidemiology: laboratory information system databases in Denmark. Clin Epidemiol. 2020;12:469–475. doi:10.2147/CLEP.S245060
   PubMed Web of Science ®Google Scholar
• Grann AF, Erichsen R, Thomsen R, et al. Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus university. Denmark Clin Epidemiol. 2011;3:133–138. doi:10.2147/CLEP.S17901
   PubMedGoogle Scholar
• Sinnott SJ, Polinski JM, Byrne S, et al. Measuring drug exposure: concordance between defined daily dose and days’ supply depended on drug class. J Clin Epidemiol. 2016;69:107–113. doi:10.1016/j.jclinepi.2015.05.026
   PubMed Web of Science ®Google Scholar
• Mach F, Baigent C, Catapano ALet al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The task force for the management of dyslipidaemias of the European society of cardiology (ESC) and European atherosclerosis society (EAS). Eur Heart J. 2019;41(1):111–188.
   Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038
   PubMed Web of Science ®Google Scholar
• Sundbøll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish national patient registry: a validation study. BMJ Open. 2016;6(11):e012832. doi:10.1136/bmjopen-2016-012832
   PubMed Web of Science ®Google Scholar
• Wellejus Albertsen L, Heide-Jørgensen U, Schmidt SAJ, et al. The DANish comorbidity index for acute myocardial infarction (DANCAMI): development, validation and comparison with existing comorbidity indices. Clin Epidemiol. 2020;12:1299–1311. doi:10.2147/CLEP.S277325
   PubMed Web of Science ®Google Scholar
• Schjerning Olsen AM, Fosbøl EL, Lindhardsen J, et al. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Circulation. 2011;123(20):2226–2235. doi:10.1161/CIRCULATIONAHA.110.004671
   PubMed Web of Science ®Google Scholar
• Schmidt M, Christiansen CF, Mehnert F, et al. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ. 2011;343:d3450. doi:10.1136/bmj.d3450
   PubMed Web of Science ®Google Scholar
• Olsen AM, Fosbøl EL, Lindhardsen J, et al. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study. Circulation. 2012;126(16):1955–1963. doi:10.1161/CIRCULATIONAHA.112.112607
   PubMed Web of Science ®Google Scholar
• Hernán MA. The hazards of hazard ratios. Epidemiology. 2010;21(1):13–15. doi:10.1097/EDE.0b013e3181c1ea43
   PubMed Web of Science ®Google Scholar
• Bonnesen K, et al. Impact of lifestyle and socioeconomic position on the association between non-steroidal anti-inflammatory drug use and major adverse cardiovascular events: a case-crossover study. Drug Saf; 2023;46:533–543. doi:10.1007/s40264-023-01298-0
   PubMed Web of Science ®Google Scholar
• Gaster N, Pedersen L, Ehrenstein V, et al. Cardiovascular risks associated with use of non-steroidal anti-inflammatory drugs in patients with non-obstructive coronary artery disease. Eur Heart J Cardiovasc Pharmacother. 2022;8(3):282–290. doi:10.1093/ehjcvp/pvab082
   PubMed Web of Science ®Google Scholar
• McGettigan P, Henry D, Strom BL. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8(9):e1001098. doi:10.1371/journal.pmed.1001098
   PubMed Web of Science ®Google Scholar
• Henriksen DP, Rasmussen L, Hansen MR, et al. Comparison of the five Danish regions regarding demographic characteristics, healthcare utilization, and medication use--a descriptive cross-sectional study. PLoS One. 2015;10(10):e0140197. doi:10.1371/journal.pone.0140197
   PubMed Web of Science ®Google Scholar
• Athanasiadis G, Cheng JY, Vilhjálmsson BJ, et al. Nationwide genomic study in Denmark reveals remarkable population homogeneity. Genetics. 2016;204(2):711–722. doi:10.1534/genetics.116.189241
   PubMed Web of Science ®Google Scholar
• Gaster N, Hallas J, Pottegård A, et al. The validity of Danish prescription data to measure use of aspirin and other non-steroidal anti-inflammatory drugs and quantification of bias due to non-prescription drug use. Clin Epidemiol. 2021;13:569–579. doi:10.2147/CLEP.S311450
   PubMed Web of Science ®Google Scholar